Incoming poxvirus dsDNA genomes differentially activate AIM2 or NLRP3 inflammasomes in human cells
Ontology highlight
ABSTRACT: The innate immune system recognizes cytosolic DNA as evidence of infection, although detailed analysis is mostly limited to mice and cell lines. To investigate inflammasome responses in human primary cells, we used the inflammasome reporter caspase-1CARD-EGFP (C1C-EGFP) encoded in engineered viruses. We found that released genomes of the model poxvirus vaccinia virus (VACV) and monkeypox virus (MPXV) trigger robust inflammasome assembly in human primary cells. To determine the involved inflammasome sensors, we generated nanobodies against AIM2. Three of them inhibit AIM2 inflammasome assembly by blocking the polymerization of the AIM2 PYD, most potently as bivalent nanobodies. Utilizing VACV expressing bivalent AIM2 nanobodies, we show that inflammasomes in primary human macrophages and keratinocytes are nucleated by AIM2, while CD14+ monocytes assemble NLRP3 inflammasomes. This resolves the discrepancy between the previously reported activation of AIM2 inflammasomes in mice and NLRP3 inflammasomes in humans and provides the first evidence of cell-type-specific regulation of DNA-triggered inflammasome activation. The newly developed AIM2-specific nanobodies offer a precise tool to dissect and potentially target AIM2 inflammasome assembly in other disease contexts.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Primary Cell, Monocyte
SUBMITTER:
Tabea Klein
LAB HEAD: Florian Schmidt
PROVIDER: PXD069678 | Pride | 2026-01-22
REPOSITORIES: Pride
ACCESS DATA